StoneX Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$280K Buy
+710
New +$300K 0.01% 865
2026
Q1
Sell
-1,448
Closed -$683K 1058
2025
Q4
$683K Buy
1,448
+10
+0.7% +$4.64K 0.03% 442
2025
Q3
$613K Buy
1,438
+256
+22% +$99.2K 0.03% 475
2025
Q2
$453K Buy
1,182
+2
+0.2% +$721 0.02% 535
2025
Q1
$408K Buy
1,180
+92
+8% +$29.6K 0.02% 529
2024
Q4
$327K Buy
1,088
+11
+1% +$3.84K 0.02% 577
2024
Q3
$438K Sell
1,077
-42
-4% -$15.4K 0.2% 146
2024
Q2
$360K Buy
1,119
+506
+83% +$164K 0.17% 174
2024
Q1
$205K Sell
613
-509
-45% -$156K 0.11% 282
2023
Q4
$304K Buy
1,122
+5
+0.4% +$1.24K 0.16% 177
2023
Q3
$275K Sell
1,117
-37
-3% -$10.1K 0.15% 202
2023
Q2
$350K Sell
1,154
-9
-0.8% -$2.5K 0.2% 147
2023
Q1
$307K Buy
1,163
+3
+0.3% +$762 0.18% 171
2022
Q4
$278K Buy
+1,160
New +$260K 0.04% 315
2022
Q2
Sell
-1,030
Closed -$258K 616
2022
Q1
$258K Buy
+1,030
New +$259K 0.02% 450

Other funds holding HCA

StoneX Group's HCA Position: Q2 2026 in Review

StoneX Group opened a new position in HCA Healthcare (HCA) in Q2 2026: 710 shares worth $280K. The stake represents 0.01% of the portfolio and ranks #865 among its holdings. This is a return to the name: StoneX Group previously reported a position in HCA as recently as Q4 2025.

StoneX Group first reported a position in HCA in Q1 2022 and has held it in 15 quarters since. The position peaked at $683K in Q4 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • StoneX Group held 710 shares of HCA Healthcare worth $280K as of Q2 2026.
  • HCA Healthcare was a new StoneX Group position in Q2 2026.
  • HCA Healthcare made up 0.01% of StoneX Group's portfolio in Q2 2026, its #865 holding.
  • StoneX Group first reported a position in HCA Healthcare in Q1 2022 and has held it in 15 quarters since.
  • StoneX Group's HCA Healthcare position peaked at $683K in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.